Yoshihisa Sasou

Director/Board Member at Medicago, Inc.

Health Technology

Profile

Yoshihisa Sasou is currently a Director at Medicago, Inc. since 2013.
Previously, he worked as a General Manager-Corporate Communications at Mitsubishi Tanabe Pharma Corp.

Yoshihisa Sasou active positions

Companies	Position	Start
Medicago, Inc. Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada.	Director/Board Member	2013-09-17

All active positions of Yoshihisa Sasou

Former positions of Yoshihisa Sasou

Companies	Position	End
MITSUBISHI TANABE PHARMA CORPORATION	Public Communications Contact	-

See the detail of Yoshihisa Sasou's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Yoshihisa Sasou's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Mitsubishi Tanabe Pharma Corp. Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan.	Health Technology
Medicago, Inc. Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada.	Health Technology